What is the share price of Themis Medicare Ltd (THEMISMED) today?
The share price of THEMISMED as on 11th March 2025 is ₹153.91. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Themis Medicare Ltd (THEMISMED) share?
The past returns of Themis Medicare Ltd (THEMISMED) share are- Past 1 week: 4.04%
- Past 1 month: -29.39%
- Past 3 months: -46.47%
- Past 6 months: -37.53%
- Past 1 year: -34.22%
- Past 3 years: 58.28%
- Past 5 years: 392.05%
What are the peers or stocks similar to Themis Medicare Ltd (THEMISMED)?
The peers or stocks similar to Themis Medicare Ltd (THEMISMED) include:What is the dividend yield % of Themis Medicare Ltd (THEMISMED) share?
The current dividend yield of Themis Medicare Ltd (THEMISMED) is 0.32.What is the market cap of Themis Medicare Ltd (THEMISMED) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Themis Medicare Ltd (THEMISMED) is ₹1436.10 Cr as of 11th March 2025.What is the 52 week high and low of Themis Medicare Ltd (THEMISMED) share?
The 52-week high of Themis Medicare Ltd (THEMISMED) is ₹317 and the 52-week low is ₹145.05.What is the PE and PB ratio of Themis Medicare Ltd (THEMISMED) stock?
The P/E (price-to-earnings) ratio of Themis Medicare Ltd (THEMISMED) is 33.00. The P/B (price-to-book) ratio is 3.80.Which sector does Themis Medicare Ltd (THEMISMED) belong to?
Themis Medicare Ltd (THEMISMED) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Themis Medicare Ltd (THEMISMED) shares?
You can directly buy Themis Medicare Ltd (THEMISMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Themis Medicare Ltd
THEMISMEDThemis Medicare Ltd
THEMISMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,436 cr, stock is ranked 1,189
High RiskStock is 3.58x as volatile as Nifty
153.911.36% (-2.12)
153.911.36% (-2.12)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 31.12 | 3.80 | 0.32% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 5.97 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.
Investor Presentation
View olderPeers
Compare with peersSUNPHARMA
PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
CIPLA
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
DRREDDY
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
MANKIND
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 235.63 | 220.73 | 215.11 | 188.69 | 213.96 | 243.77 | 412.49 | 379.44 | 405.32 | 449.82 | ||||||||||
Raw Materials | 87.38 | 74.53 | 73.15 | 68.81 | 66.67 | 79.48 | 145.08 | 126.16 | 138.28 | 370.06 | ||||||||||
| Power & Fuel Cost | 10.83 | 9.77 | 8.41 | 9.70 | 11.49 | 11.32 | 12.18 | 11.83 | 13.46 | |||||||||||
| Employee Cost | 36.30 | 40.00 | 44.65 | 45.69 | 44.28 | 39.99 | 51.97 | 66.15 | 82.41 | |||||||||||
| Selling & Administrative Expenses | 26.87 | 35.57 | 37.20 | 35.28 | 26.34 | 26.96 | 44.73 | 51.04 | 59.01 | |||||||||||
| Operating & Other expenses | 32.90 | 23.98 | 21.08 | 22.00 | 17.15 | 23.43 | 45.02 | 31.70 | 37.09 | |||||||||||
EBITDA | 41.35 | 36.88 | 30.62 | 7.21 | 48.03 | 62.59 | 113.51 | 92.56 | 75.07 | 79.76 | ||||||||||
| Depreciation/Amortization | 11.89 | 7.47 | 7.42 | 7.99 | 8.27 | 8.55 | 9.48 | 10.49 | 12.25 | 10.46 | ||||||||||
| PBIT | 29.46 | 29.41 | 23.20 | -0.78 | 39.76 | 54.04 | 104.03 | 82.07 | 62.82 | 69.30 | ||||||||||
| Interest & Other Items | 12.33 | 11.84 | 11.87 | 11.82 | 12.88 | 12.71 | 8.77 | 9.56 | 9.38 | 9.75 | ||||||||||
| PBT | 17.13 | 17.57 | 11.33 | -12.60 | 26.88 | 41.33 | 95.26 | 72.51 | 53.44 | 59.55 | ||||||||||
| Taxes & Other Items | 0.85 | 1.60 | 0.04 | -1.86 | 2.09 | 5.63 | 22.38 | 15.61 | 9.92 | 13.41 | ||||||||||
| Net Income | 16.28 | 15.97 | 11.29 | -10.74 | 24.79 | 35.70 | 72.88 | 56.90 | 43.52 | 46.14 | ||||||||||
| EPS | 1.92 | 1.82 | 1.24 | -1.17 | 2.70 | 3.89 | 7.93 | 6.18 | 4.73 | 5.01 | ||||||||||
| DPS | 0.18 | 0.00 | 0.00 | 0.00 | 0.18 | 0.43 | 0.50 | 0.50 | 0.50 | 0.50 | ||||||||||
| Payout ratio | 0.09 | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.06 | 0.08 | 0.11 | 0.10 |
Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2025
Investor Presentation
Feb 14PDF
Oct 25PDF
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Themis Medicare Ltd | 33.00 | 3.80 | 0.32% |
| Sun Pharmaceutical Industries Ltd | 40.38 | 5.76 | 0.84% |
| Cipla Ltd | 28.66 | 4.41 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.75 | 15.16 | 0.91% |
Price Comparison
Compare THEMISMED with any stock or ETFCompare THEMISMED with any stock or ETF
THEMISMED
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Mutual Funds Holding Trend
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Themis Medicare Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.04% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 95/103 (-11) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
THEMISMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.32%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.20 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 12, 2024
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Jul 12, 2024
Cash Dividend
Ex DateEx DateSep 1, 2023
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Sep 1, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Sep 8, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Final
Final | Div/Share: ₹4.30
Dividend/Share
₹4.30
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Sep 17, 2020
News & Opinions
Articles & Videos
Earnings
Themis Medicare consolidated net profit declines 92.94% in the December 2024 quarter
Net profit of Themis Medicare declined 92.94% to Rs 0.52 crore in the quarter ended December 2024 as against Rs 7.37 crore during the previous quarter ended December 2023. Sales rose 13.70% to Rs 93.81 crore in the quarter ended December 2024 as against Rs 82.51 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.8182.51 14 OPM %6.369.77 - PBDT4.2011.31 -63 PBT1.668.22 -80 NP0.527.37 -93 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Themis Medicare to discuss results
Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
Themis Medicare consolidated net profit rises 26.24% in the September 2024 quarter
Net profit of Themis Medicare rose 26.24% to Rs 14.29 crore in the quarter ended September 2024 as against Rs 11.32 crore during the previous quarter ended September 2023. Sales rose 11.67% to Rs 117.01 crore in the quarter ended September 2024 as against Rs 104.78 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales117.01104.78 12 OPM %14.6411.84 - PBDT20.2517.03 19 PBT17.8013.96 28 NP14.2911.32 26 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Themis Medicare to discuss results
Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live
4 months agoCapital Market - Live
Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter
7 months agoBusiness Standard
Earnings
Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter
Net profit of Themis Medicare rose 35.68% to Rs 24.68 crore in the quarter ended June 2024 as against Rs 18.19 crore during the previous quarter ended June 2023. Sales rose 27.25% to Rs 122.99 crore in the quarter ended June 2024 as against Rs 96.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales122.9996.65 27 OPM %23.7322.49 - PBDT33.7525.54 32 PBT31.3522.52 39 NP24.6818.19 36 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Themis Medicare to hold board meeting
Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Themis Medicare Standalone March 2023 Net Sales at Rs 80.10 crore, up 0.39% Y-o-Y
1 year agoMoneycontrol
Themis Medicare gains on DCGI nod for Remifentanil injection
2 years agoBusiness Standard
Stocks To Watch: Reliance Industries, Advanced Enzyme, NTPC, Themis Medicare
2 years agoBloomberg Quint
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 16.52%, vs industry avg of 9.04%
Increasing Market Share
Over the last 5 years, market share increased from 0.09% to 0.11%